| ISIN | CH1234507353 |
|---|---|
| Valor Number | 123450735 |
| Bloomberg Global ID | |
| Fund Name | BLKB Equity Switzerland Focus It |
| Fund Provider |
Basellandschaftliche Kantonalbank
Lieastal, Swi tzerland Phone: +41 61 925 94 94 E-Mail: info@blkb.ch Web: www.blkb.ch |
| Fund Provider | Basellandschaftliche Kantonalbank |
| Representative in Switzerland | |
| Distributor(s) |
Basellandschaftliche Kantonalbank Liestal Phone: +41 61 925 94 94 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 119.71 CHF | 19.01.2026 |
|---|---|---|
| Previous Price * | 121.57 CHF | 16.01.2026 |
| 52 Week High * | 122.06 CHF | 15.01.2026 |
| 52 Week Low * | 98.62 CHF | 09.04.2025 |
| NAV * | 119.71 CHF | 19.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 107,754,823 | |
| Unit/Share Assets *** | 1,895,699 | |
| Trading Information SIX | ||
| YTD Performance | +1.04% |
31.12.2025 - 19.01.2026
31.12.2025 19.01.2026 |
|---|---|---|
| 1 month | +1.67% |
19.12.2025 - 19.01.2026
19.12.2025 19.01.2026 |
| 3 months | +4.98% |
20.10.2025 - 19.01.2026
20.10.2025 19.01.2026 |
| 6 months | +4.33% |
21.07.2025 - 19.01.2026
21.07.2025 19.01.2026 |
| 1 year | +5.78% |
20.01.2025 - 19.01.2026
20.01.2025 19.01.2026 |
| 2 years | +22.11% |
19.01.2024 - 19.01.2026
19.01.2024 19.01.2026 |
| 3 years | +21.76% |
20.02.2023 - 19.01.2026
20.02.2023 19.01.2026 |
| 5 years | - | - |
| Equity Participation Rate in % | 99.22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 8.87% | |
|---|---|---|
| Nestle SA | 8.29% | |
| UBS Group AG Registered Shares | 7.02% | |
| Novartis AG Registered Shares | 6.64% | |
| Holcim Ltd | 6.08% | |
| ABB Ltd | 5.52% | |
| Compagnie Financiere Richemont SA Class A | 5.13% | |
| Lonza Group Ltd | 4.01% | |
| Amrize Ltd Registered Share | 3.87% | |
| Alcon Inc | 3.12% | |
| Last data update | 31.12.2025 | |
| TER | 0.70% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.80% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |